Gilead sets price for five-day coronavirus treatment at $2,340
A five-day course of a potential COVID-19 treatment will cost the U.S. government and other developed countries $2,340 per patient, Gilead Sciences announced Monday.Private insurers will pay $3,120 for a five-day course of remdesivir, which has...
Source: https://ift.tt/2ZyHwM3
A five-day course of a potential COVID-19 treatment will cost the U.S. government and other developed countries $2,340 per patient, Gilead Sciences announced Monday.Private insurers will pay $3,120 for a five-day course of remdesivir, which has...
Source: https://ift.tt/2ZyHwM3
0 Comments